Subscribe

SEARCH RESULT

Wednesday, December 9, 2020
Boehringer Ingelheim joins International Poultry Council
Boehringer Ingelheim has joined the International Poultry Council (IPC) as its new Associate Member.
Wednesday, October 28, 2020
Boehringer Ingelheim in partnership to develop needle free injection device for pigs
Boehringer Ingelheim has partnered with Henke-Sass, Wolf, a leading medical technology company in Germany, to develop an innovative intramuscular needle free vaccine injection tool for pigs around weaning until the end of nursery.
Wednesday, October 7, 2020
Boehringer Ingelheim awards winners of the 2020 European PRRS research
Boehringer Ingelheim has honoured three winning research proposals with a funding of 25,000 euro (~US$29,400; 1 euro = US1.18) each as part of the European PRRS Awards to encourage further development of practical methods for controlling PR ...
Monday, October 5, 2020
Boehringer Ingelheim: New study shows vaccination leads to increased milk production
Boehringer Ingelheim has announced that cattle producers can confidently use its live double deleted BVDV (bovine viral diarrhea virus) vaccine Bovela® to control BVD.
Tuesday, July 28, 2020
Boehringer Ingelheim acquires GST to strengthen stem cell capabilities in animal health
Boehringer Ingelheim has acquired Global Stem cell Technology (GST), a Belgian veterinary biotech company.
Tuesday, July 21, 2020
University of Queensland partners with Boehringer Ingelheim on development of natural antiparasitics
Professor Robert Capon and Dr. Zeinab Khalil from University of Queensland's Institute for Molecular Bioscience have been awarded a A$700,000 (~US$492,000) Australian Research Council Linkage Grant to partner with Boehringer Ingelheim Anima ...
Friday, June 26, 2020
Boehringer Ingelheim's Classical Swine Fever live vaccine gets approval
Boehringer Ingelheim announced that its China-developed Classical Swine Fever Vaccine, Live has recently obtained a "New Veterinary Drug Registration Certificate" from the Ministry of Agriculture and Rural Affairs of China.
Friday, June 12, 2020
Boehringer Ingelheim announces LastMile initiative for animal healthcare in Africa
Boehringer Ingelheim's LastMile initiative is an integrated, solutions-driven programme seeking to address crucial animal health challenges by making animal medical resources available in hard-to-reach areas, the company announced.
Tuesday, May 26, 2020
Boehringer Ingelheim announces winners of 2020 BVDzero Case Awards
Boehringer Ingelheim has announced the winners of the 2020 BVDzero Case Awards. This biennial initiative reflects Boehringer Ingelheim's long-term commitment to promoting health and well-being of farm animals.
Wednesday, May 20, 2020
Boehringer projects good animal health sales to Brazil livestock industry
The Brazil Boehringer Ingelheim's animal health division said the COVID-19 pandemic has slowed demand for veterinary medical products in country, but projects good sales for the major global meat producer and supplier,reported Reuters.
Tuesday, April 14, 2020
Boehringer Ingelheim calls for PRRS research award submissions
For the fifth year, Boehringer Ingelheim sponsors the European PRRS Research Award to support applied research for improved control of the Porcine Reproductive and Respiratory Syndrome (PRRS).
Tuesday, February 18, 2020
Boehringer Ingelheim kicks off project based on behavioural science to improve cattle well-being
February 18, 2020 Boehringer Ingelheim kicks off project based on behavioural science to improve cattle well-being Boehringer Ingelheim launches an innovative project to better understand human behaviours associated with pain management in ...
Tuesday, January 7, 2020
Boehringer Ingelheim US launches trivalent poultry vaccine
Boehringer Ingelheim's US Animal Health Business launched a vaccine January 6 to protect poultry from three diseases.
Wednesday, October 23, 2019
Boehringer Ingelheim completes US$76-million expansion of US vaccine plant
October 23, 2019 Boehringer Ingelheim completes US$76-million expansion of US vaccine plant Boehringer Ingelheim has completed its US$76 million expansion of its vaccine manufacturing plant in Athens, Georgia, allowing it to double the faci ...
Tuesday, October 1, 2019
Boehringer Ingelheim obtains EMA authorisation for new porcine parvovirus vaccine
After obtaining the marketing authorisation from the European Commission, Boehringer Ingelheim launches Reprocyc® ParvoFLEX in selected countries within the EU, a new porcine parvovirus vaccine to protect swine foetuses against transpl ...
Video >
Most popular

Follow Us

FacebookTwitterLinkedIn
About Us
Company Profile
Our Team
Our Products & Services
Subscription
eNewsletter
Inquiry
Contact Us
Advertise With Us
Partner With Us
We use cookies to understand how you use our website and to improve your browsing experience.
This includes personalizing content and advertising. By continuing to use our website, you accept our use of cookies, updated Privacy Statement and Terms of Use.
Copyright ©2001 - 2025 eFeedLink. All rights reserved.